28Apr 2023
Outcomes From a Prospectively Implemented Protocol Using Apixaban After Robotic Radical Cystectomy

Outcomes From a Prospectively Implemented Protocol Using Apixaban After Robotic Radical Cystectomy

This study aimed to compare the safety and efficacy of oral Apixaban with injectable Enoxaparin for venous thromboembolism (VTE) prophylaxis after robotic-assisted radical cystectomy (RARC). The retrospective review included 124 patients receiving Apixaban prophylaxis and 250 patients receiving Enoxaparin prophylaxis. The primary outcome was the incidence of symptomatic VTE confirmed with definitive imaging within 90 days of RARC. The study found no statistically significant difference in VTE rates between the two groups. The study concluded that Apixaban appears safe and effective for VTE prophylaxis after RARC.

  • #urology

Like

Save

Share